Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First in Human (FIH) Clinical Study to Evaluate the Initial Safety and Preliminary Efficacy of the Suture-Mediated Novelrad Vascular Closure System

NCT07858903 is registered in ClinicalTrials.gov with Novelrad Ltd. as lead sponsor.

NCT NCT07858903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07858903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First in Human (FIH) Clinical Study to Evaluate the Initial Safety and Preliminary Efficacy of the Suture-Mediated Novelrad Vascular Closure System
Lead sponsor
Novelrad Ltd.
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2025
Completion date
August 18, 2026
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

femoral access site closure, femoral arteriotomy closure, vascular closure device